eBird Company Overview, Contact Details & Competitors

Insights

Gathering insights about eBird…

Similar companies to eBird

RSPB
$100M$1B

eBird Tech Stack

eBird uses 8 technology products and services including Apache Spark, Drupal, WordPress, and more. Explore eBird's tech stack below.

Apache Spark
Big Data Processing
Drupal
Content Management System
WordPress
Content Management System
Google Cloud
Infrastructure As A Service
Vue.js
Javascript Frameworks
Google
Miscellaneous
Envoy
Web And Application Servers
Apache
Web Servers

Media & News

bluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene autotemcel) Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology (ASH) Annual Meeting and Exposition
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced new and updated data from LYFGENIA™ (lovotobegligene autotemcel, or lovo-cel) gene therapy for patients with sickle cell disease who have a history of vaso-occlusive events (VOEs). The data will be presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in an oral presentation on Sunday, December 8 at 9:30 a.m. Pacific Time and a poster presentation on Sunday, December 8 at 6 p.
Dec 08, 2024 | www.businesswire.com
Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced updated data from patients with beta-thalassemia who require regular blood transfusions treated with betibeglogene autotemcel (beti-cel, approved commercially as ZYNTEGLO™) in clinical studies. The data was presented today at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition. “Updated follow-up data of up to 10 years showed that patients treated with beti-cel in clinical trials experi.
Dec 07, 2024 | www.businesswire.com
ISS Recommends Dye & Durham Shareholders Vote the BLUE Proxy Card “FOR” Three of Engine Capital's Directors, Including Proposed Chair and Interim CEO Hans Gieskes
NEW YORK--(BUSINESS WIRE)--Engine Capital LP (together with its affiliates, "Engine" or "we"), which owns approximately 7.1% of the issued and outstanding common shares of Dye & Durham Limited (TSX: DND) ("Dye & Durham" or the "Company"), today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, has recommended that Dye & Durham shareholders support meaningful boardroom change by voting for three of its six directors at the Comp.
Dec 06, 2024 | www.businesswire.com
bluebird bio Announces 1-for-20 Reverse Stock Split
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today announced that it will proceed with a 1-for-20 reverse stock split (“Reverse Stock Split”) of the Company's common stock following approval by both its Board of Directors and BLUE stockholders at its reconvened annual meeting held on December 4, 2024. As previously announced, the primary goal of the Reverse Stock Split is to increase the per share market price of the Company's common st.
Dec 04, 2024 | www.businesswire.com
bluebird bio Confirms Participation in Center for Medicare and Medicaid Innovation (CMMI) Cell and Gene Therapy Access Model
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio”) today announced it has reached an agreement with the Center for Medicare and Medicaid Innovation to offer an outcomes-based agreement for LYFGENIA gene therapy under the Cell and Gene Therapy (CGT) Access Model. LYFGENIA is a one-time gene therapy approved for the treatment of patients 12 years of age and older with sickle cell disease and a history of vaso-occlusive events (VOEs). “Ensuring timely, equitable.
Dec 04, 2024 | www.businesswire.com
THE DISTINCT COBALT BLUE OF SARATOGA® SPRING WATER NOW HAS AN OFFICIAL PANTONE® COLOR: SARATOGA® SIGNATURE BLUE, COLOR 286 C
Official designation by the global authority on color to anchor creative programming at Design Miami, and partnerships with acclaimed chef Curtis Stone and Television Personality Kathy Hilton TAMPA, Fla. and STAMFORD, Conn.
Dec 02, 2024 | www.prnewswire.com
FDA investigates risk of blood cancers from bluebird bio's gene therapy
The U.S. Food and Drug Administration said on Wednesday it is investigating reports of blood cancers in patients who were treated with bluebird bio's gene therapy Skysona.
Nov 27, 2024 | www.reuters.com

eBird's Email Address Formats

eBird uses at least 1 format(s):

eBird Email Formats	Example	Percentage
First.Last@ebird.org	John.Doe@ebird.org	50%
First.Last@ebird.org	John.Doe@ebird.org	50%

Frequently Asked Questions

Where is eBird's headquarters located?

eBird's main headquarters is located at Ithaca, New York US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is eBird's stock symbol?

eBird is a publicly traded company; the company's stock symbol is BLUE.

What is eBird's official website and social media links?

eBird's official website is ebird.org and has social profiles on LinkedIn.

How much revenue does eBird generate?

As of April 2021, eBird's annual revenue reached $1.7M.

What is eBird's SIC code NAICS code?

eBird's SIC code is 6163 - Loan Brokers NAICS code is 611310 - Colleges, Universities, and Professional Schools.

How many employees does eBird have currently?

As of April 2021, eBird has approximately 2 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Research And Development Staff: D. F.Librarian: M. Y.Member: R. F.. Explore eBird's employee directory with LeadIQ.

What industry does eBird belong to?

eBird operates in the Writing and Editing industry.

What technology does eBird use?

eBird's tech stack includes Apache SparkDrupalWordPressGoogle CloudVue.jsGoogleEnvoyApache.

What is eBird's email format?

eBird's email format typically follows the pattern of . Find more eBird email formats with LeadIQ.

Insights

Similar companies to eBird

RSPB

eBird Tech Stack

Media & News

bluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene autotemcel) Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology (ASH) Annual Meeting and Exposition

Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels

ISS Recommends Dye & Durham Shareholders Vote the BLUE Proxy Card “FOR” Three of Engine Capital's Directors, Including Proposed Chair and Interim CEO Hans Gieskes

bluebird bio Announces 1-for-20 Reverse Stock Split

bluebird bio Confirms Participation in Center for Medicare and Medicaid Innovation (CMMI) Cell and Gene Therapy Access Model

THE DISTINCT COBALT BLUE OF SARATOGA® SPRING WATER NOW HAS AN OFFICIAL PANTONE® COLOR: SARATOGA® SIGNATURE BLUE, COLOR 286 C

FDA investigates risk of blood cancers from bluebird bio's gene therapy

eBird's Email Address Formats

Frequently Asked Questions

Where is eBird's headquarters located?

What is eBird's stock symbol?

What is eBird's official website and social media links?

How much revenue does eBird generate?

What is eBird's SIC code NAICS code?

How many employees does eBird have currently?

What industry does eBird belong to?

What technology does eBird use?

What is eBird's email format?

eBird

Company Overview

Media & News

bluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene autotemcel) Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology (ASH) Annual Meeting and Exposition

Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels

ISS Recommends Dye & Durham Shareholders Vote the BLUE Proxy Card “FOR” Three of Engine Capital's Directors, Including Proposed Chair and Interim CEO Hans Gieskes

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?